ATE159170T1 - Impfstoffe und diagnosetest für haemophilus influenzae - Google Patents
Impfstoffe und diagnosetest für haemophilus influenzaeInfo
- Publication number
- ATE159170T1 ATE159170T1 AT88900927T AT88900927T ATE159170T1 AT E159170 T1 ATE159170 T1 AT E159170T1 AT 88900927 T AT88900927 T AT 88900927T AT 88900927 T AT88900927 T AT 88900927T AT E159170 T1 ATE159170 T1 AT E159170T1
- Authority
- AT
- Austria
- Prior art keywords
- proteins
- peptides
- viruses
- pbomp
- influenzae
- Prior art date
Links
- 241000606768 Haemophilus influenzae Species 0.000 title abstract 4
- 229940047650 haemophilus influenzae Drugs 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 238000002405 diagnostic procedure Methods 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 7
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 7
- 108090000623 proteins and genes Proteins 0.000 abstract 7
- 102000004169 proteins and genes Human genes 0.000 abstract 7
- 241000700605 Viruses Species 0.000 abstract 4
- 238000000034 method Methods 0.000 abstract 3
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 2
- 239000013598 vector Substances 0.000 abstract 2
- 108020004414 DNA Proteins 0.000 abstract 1
- 241000238631 Hexapoda Species 0.000 abstract 1
- 108060003951 Immunoglobulin Proteins 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 101710116435 Outer membrane protein Proteins 0.000 abstract 1
- 108020004511 Recombinant DNA Proteins 0.000 abstract 1
- 108020005202 Viral DNA Proteins 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 238000009396 hybridization Methods 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 238000003018 immunoassay Methods 0.000 abstract 1
- 102000018358 immunoglobulin Human genes 0.000 abstract 1
- 229940072221 immunoglobulins Drugs 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 241001515965 unidentified phage Species 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1242—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Plant Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Mycology (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94836486A | 1986-12-31 | 1986-12-31 | |
| US2084987A | 1987-03-02 | 1987-03-02 | |
| US13207387A | 1987-12-11 | 1987-12-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE159170T1 true ATE159170T1 (de) | 1997-11-15 |
Family
ID=27361526
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT88900927T ATE159170T1 (de) | 1986-12-31 | 1987-12-23 | Impfstoffe und diagnosetest für haemophilus influenzae |
Country Status (9)
| Country | Link |
|---|---|
| EP (2) | EP0294469B1 (de) |
| JP (5) | JP2534529B2 (de) |
| KR (1) | KR960016208B1 (de) |
| AT (1) | ATE159170T1 (de) |
| AU (1) | AU615429B2 (de) |
| CA (1) | CA1335655C (de) |
| DE (1) | DE3752131T2 (de) |
| DK (1) | DK482788A (de) |
| WO (1) | WO1988004932A1 (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5300632A (en) * | 1986-11-18 | 1994-04-05 | Research Foundation Of State University Of New York | Method for purifying an outer membrane protein of Haemophilus influenzae |
| NZ219515A (en) * | 1987-02-10 | 1989-09-27 | Wellcome Found | Fusion proteins comprising influenza virus ha and a nonnatural antigenic epitope |
| AU623353B2 (en) * | 1987-12-10 | 1992-05-14 | Board Of Regents, The University Of Texas System | Methods and compositions for the production of haemophilus influenzae type b major outer membrane protein antigens |
| CA1340888C (en) * | 1988-09-01 | 2000-02-01 | Algis Anilionis | Vaccines and diagnostic assays for haemophilus influenzae |
| KR100188323B1 (ko) * | 1989-03-09 | 1999-06-01 | 이곤 이이 버어그 | 비타입성 헤모필루스 인플렌자에 대한 백신 |
| ES2081864T3 (es) * | 1989-03-29 | 1996-03-16 | Univ New York State Res Found | Metodo para purificar una proteina de la membrana exterior de haemophilus influenzae. |
| FI903414A (fi) * | 1990-07-06 | 1992-01-07 | Kansanterveyslaitos | Produktion av proteiner i grampositiva bakterier. |
| ATE158080T1 (de) * | 1991-10-01 | 1997-09-15 | Biostar Inc | Hochempfindlicher optischer immunoassay durch gebrauch von enzymmarkierten reagenz |
| GB9202219D0 (en) * | 1992-02-03 | 1992-03-18 | Connaught Lab | A synthetic heamophilus influenzae conjugate vaccine |
| DE4232073C2 (de) * | 1992-09-25 | 2001-09-20 | Chiron Behring Gmbh & Co | Verfahren zur immunchemischen Quantifizierung von inaktivierten, immunreaktiven Antigenen |
| JPH07245887A (ja) * | 1994-03-08 | 1995-09-19 | Rhythm Watch Co Ltd | バックアップバッテリー回路 |
| NZ537171A (en) * | 2002-01-25 | 2005-11-25 | Erico Int Corp | Welding apparatus and method |
| US7786279B2 (en) | 2003-02-27 | 2010-08-31 | Yeda Research And Development Co. Ltd. | Nucleic acid molecules, polypeptides, antibodies and compositions for treating and detecting influenza virus infection |
| CA2838188C (en) | 2011-06-04 | 2017-04-18 | Rochester General Hospital Research Institute | Compositions and methods related to p6 of haemophilus influenzae |
| JP5396498B2 (ja) | 2012-03-02 | 2014-01-22 | 株式会社エス・ケー・ジー | 発光装置 |
| CN105242040B (zh) * | 2014-08-18 | 2017-01-18 | 董俊 | 人流感嗜血杆菌量子点免疫层析检测卡及其制备方法和应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US304863A (en) | 1884-09-09 | Railway car | ||
| US4237224A (en) | 1974-11-04 | 1980-12-02 | Board Of Trustees Of The Leland Stanford Jr. University | Process for producing biologically functional molecular chimeras |
| US4261968A (en) * | 1979-05-10 | 1981-04-14 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4358535A (en) * | 1980-12-08 | 1982-11-09 | Board Of Regents Of The University Of Washington | Specific DNA probes in diagnostic microbiology |
| FI63596C (fi) * | 1981-10-16 | 1983-07-11 | Orion Yhtymae Oy | Mikrobdiagnostiskt foerfarande som grundar sig pao skiktshybridisering av nukleinsyror och vid foerfarandet anvaenda kombinationer av reagenser |
| US4455296A (en) * | 1982-02-02 | 1984-06-19 | Board Of Regents, The University Of Texas System | Hybrid cell lines producing monoclonal antibodies directed against Haemophilus influenzae |
| GB8426469D0 (en) * | 1984-10-19 | 1984-11-28 | Technology Licence Co Ltd | Monoclonal antibodies |
| US5173294A (en) * | 1986-11-18 | 1992-12-22 | Research Foundation Of State University Of New York | Dna probe for the identification of haemophilus influenzae |
-
1987
- 1987-02-02 JP JP62501089A patent/JP2534529B2/ja not_active Expired - Lifetime
- 1987-12-23 JP JP63501089A patent/JP2872254B2/ja not_active Expired - Lifetime
- 1987-12-23 EP EP88900927A patent/EP0294469B1/de not_active Expired - Lifetime
- 1987-12-23 EP EP96119698A patent/EP0786472A1/de not_active Withdrawn
- 1987-12-23 DE DE3752131T patent/DE3752131T2/de not_active Expired - Lifetime
- 1987-12-23 KR KR1019880701053A patent/KR960016208B1/ko not_active IP Right Cessation
- 1987-12-23 WO PCT/US1987/003423 patent/WO1988004932A1/en active IP Right Grant
- 1987-12-23 AT AT88900927T patent/ATE159170T1/de not_active IP Right Cessation
- 1987-12-23 AU AU11541/88A patent/AU615429B2/en not_active Expired
- 1987-12-24 CA CA000555440A patent/CA1335655C/en not_active Expired - Lifetime
-
1988
- 1988-08-30 DK DK482788A patent/DK482788A/da not_active Application Discontinuation
-
1997
- 1997-04-18 JP JP9101865A patent/JP3066339B2/ja not_active Expired - Lifetime
-
1998
- 1998-09-01 JP JP10247197A patent/JP3023089B2/ja not_active Expired - Lifetime
- 1998-11-30 JP JP10340385A patent/JP3124753B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DK482788D0 (da) | 1988-08-30 |
| JPH11253160A (ja) | 1999-09-21 |
| JPH1057059A (ja) | 1998-03-03 |
| JP2872254B2 (ja) | 1999-03-17 |
| EP0294469A4 (de) | 1990-02-05 |
| EP0294469B1 (de) | 1997-10-15 |
| JP3124753B2 (ja) | 2001-01-15 |
| JPH11146797A (ja) | 1999-06-02 |
| DE3752131D1 (de) | 1997-11-20 |
| WO1988004932A1 (en) | 1988-07-14 |
| KR890700030A (ko) | 1989-03-02 |
| AU615429B2 (en) | 1991-10-03 |
| JP3023089B2 (ja) | 2000-03-21 |
| DE3752131T2 (de) | 1998-02-26 |
| EP0294469A1 (de) | 1988-12-14 |
| EP0786472A1 (de) | 1997-07-30 |
| JPS63502314A (ja) | 1988-09-01 |
| AU1154188A (en) | 1988-07-27 |
| JP3066339B2 (ja) | 2000-07-17 |
| JP2534529B2 (ja) | 1996-09-18 |
| JPH01502190A (ja) | 1989-08-03 |
| CA1335655C (en) | 1995-05-23 |
| DK482788A (da) | 1988-10-31 |
| KR960016208B1 (ko) | 1996-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE159170T1 (de) | Impfstoffe und diagnosetest für haemophilus influenzae | |
| Kohsaka et al. | Fine epitope mapping of the human SS-B/La protein. Identification of a distinct autoepitope homologous to a viral gag polyprotein. | |
| ES2144424T5 (es) | Vacuna que comprende parte de la region constante de ige para el tratamiento de reacciones alergicas inducidas por ige. | |
| SE8701413D0 (sv) | Expression and purification of an htlv-iii gag/env gene protein | |
| BR9307510A (pt) | Molécula de ácido nucleico purificada e isolada plasmídeo recombinante adaptado para transformação de hospedeiro vector recombinante adaptado para transformação de célula hospedeira proteína purificada e isolada proteína de membrana externa d15 peptídio sintético molécula quimérica composição imunogênica e anti-soro ou anticorpo | |
| KR830006423A (ko) | 특정한 항원성 결정인자인 합성펩티드 및 이로부터 항원을 제조하는 방법 | |
| DK672789D0 (da) | Nukleinsyresekvens samt rekombinant vaertscelle transformeret med samme | |
| RU2146292C1 (ru) | Последовательность днк, гибридизационная проба, олигонуклеотид (варианты), вакцины, cav-белок (варианты), диагностические наборы и штамм e.coli | |
| Kobune et al. | Characterization of measles viruses isolated after measles vaccination | |
| DK0728200T3 (da) | Haemophilus-transferrin-receptorgener | |
| ATE124420T1 (de) | Impfstoffe und testsätze für haemophilus influenzae. | |
| KR930702942A (ko) | 재조합 고양이 코로나바이러스 에스 단백질 | |
| KR100366482B1 (ko) | 백신으로서 정제된 분류가능하지 않은 헤모필루스 인프루엔자 p5단백질, 및 그의 정제방법 | |
| ATE82985T1 (de) | Strukturelles phosphoprotein (pp 150) des menschlichen cytomegalovirus, seine herstellung und verwendung. | |
| NO902251L (no) | Fremstilling av gonoreiske p1-proteiner og vaksiner. | |
| DK0491824T3 (da) | Humane parvovirus B19-proteiner og viruslignende partikler, deres fremstilling og deres anvendelse til diagnostiske bestemmelser og vacciner | |
| FI885296A0 (fi) | Rekombinant hiv-2 polypeptid. | |
| EP0236977A3 (de) | Impfstoffe gegen Rindervirus-Diarrhoe und Schweine-Cholera | |
| NZ242707A (en) | Nucleotide sequence and polypeptide of mareks disease virus and vaccine containing the polypeptide | |
| ATE274059T1 (de) | Transferrinrezeptorgene | |
| ATE366583T1 (de) | Identifizierung von spezifischen differenziell exprimierten antigenen aus mycobacterium und medizinische verwendung der mycobakteriumproteine rv0068 und rv3407 | |
| DE3877136D1 (de) | Rekombinantes histidinreiches protein von plasmodium falciparum, seine herstellung und verwendung. | |
| Bopp et al. | Comparative studies on novel protein antigens of streptococci of the serological group B | |
| RU92004487A (ru) | Днк, полипептид, вакцина, вектор, микроорганизм, клетка насекомого, реагент, способы лечения и профилактики, способ обнаружения антигенов | |
| MX9709527A (es) | Genes receptores de transferrina. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| EELA | Cancelled due to lapse of time |